SlideShare ist ein Scribd-Unternehmen logo
1 von 20
ONCOLOGY 
September, 2014 
This information is confidential and copyrighted by The Navicor Group Inc., Westerville, OH.
We are driven by a passion 
for transforming products into 
brands and patients into 
survivors.
The Navicor Group 
• is a 100% healthcare-focused, full-service agency 
• understands the unique aspects of the oncology marketplace 
• has extensive launch experience 
• has broad and vast oncology experience 
• has partnerships with large and small pharma and biotech companies 
• is part of the inVentiv Health family of companies
Accelerating performance 
inVentiv Health offers best-in-class clinical, consulting, and 
commercial services to global companies seeking 
to accelerate performance. 
With 13,600 employees in 40 countries, we rapidly 
transform promising ideas 
into commercial reality. 
4
Core capabilities 
Services include: 
 Outsourced sales teams and 
sales support 
 Advertising, branding and PR 
 Digital and closed loop marketing 
 Patient outcomes, REMS and 
Rx access/adherence 
 Medical education 
Services include: 
 Phase I-II 
(FIH or bioequivalence studies) 
 Phase IIb – Phase IV studies 
 Strategic partnerships 
 Bioanalytical services 
 Clinical data services/technology 
 Staffing services 
Consulting practices include: 
 Brand management 
 Business development 
 Clinical development 
 Medical affairs 
 Pricing and market access 
 Sales 
One of the industry’s 
top global CROs 
World’s leading provider of sales, 
marketing, and communications 
solutions for the healthcare industry 
The leading management 
consulting group specializing 
in biopharma 
5
Access to convergent services to solve challenges 
Public 
relations 
Patient 
access 
Sales force 
deployment 
KOL 
development 
Patient 
education 
Market 
research 
Launch 
planning 
CRM 
Publication 
planning 
Clinical
Transcending every intersection point along 
the life cycle continuum 
7 
Scientific 
Platform 
Disease 
Awareness 
Advisory 
Boards 
Service 
Brands 
Direct to Patient 
Core 
Promotional 
Execution 
Consultancy 
Core 
Messaging 
Specialized 
Services 
Digital Strategy 
and Relationship 
Marketing 
Tactical and 
Channel 
Planning 
Brand 
Strategy 
Customer 
Insights 
Branding and 
Campaign 
Oncology/Hematology 
Centers of Excellence
Our collective experience 
is broad and deep 
Custirsen 
Ganetespib 
Apatorsen 
Bold denotes current clients 
Vosaroxin 
Rociletinib 
Rolapitant
Navicor has unmatched experience in working with companies 
to transform development into their first commercial reality 
Our experience can benefit you in a multitude of ways 
Market prep and launch 
(products not yet available) 
 Thorough knowledge of oncology 
 Position the product and the company 
 Understand OPDP reviews 
 Traditional and accelerated filings 
 Work within limited commercial infrastructure 
Market prep and launch 
AOR assignments 
 Define and shape new expectations for a disease 
 Partner across the commercial players: 
− Market planning 
− Sales training 
− Medical affairs 
 Efficiency across commercial needs
Our account management philosophy 
is rooted in partnership 
Clearly define expectations 
Successful 
partnership and 
brand success 
Timely feedback 
Honest transparency 
Continuous dialogue 
Subjective and objective metrics
Agency Philosophy 
We believe we can make a difference 
Each one of us is inspired by the patients whose lives we help touch. 
We are motivated to set expectations, think originally, and behave differently. 
We believe that everyone is an idea person 
We operate in an intimate structure free from traditional agency barriers. 
Creative and strategy are not limited to certain departments. 
We believe intellectual rigor is imperative 
Creative communication and strategy must go beyond current indications and 
demonstrate foresight with regard to emerging data. 
We believe in collaborative relationships 
Our ideal client-agency partnership is one that fosters connections. 
We want to foster relationships with clients who are looking to 
improve patient outcomes
Based on years of client feedback, our 
areas of strength include: 
Scientific acumen 
• We hold ourselves accountable to be 
specialists in the field of oncology. 
• We have seasoned executives with broad 
oncology experience and PhD-level 
writers who specialize in oncology. 
Strategic thinking 
 By focusing on oncology, we are able to go into greater 
depth of strategic thought about our clients’ products 
and challenges. 
 We truly understand market implications within the 
oncology space and develop appropriate plans and 
programs to address key insights. 
Collaborative relationships 
 We believe that our best work is done in 
collaboration within our agency structure and 
with our clients. 
 We get the best results and have more fun 
when we collaborate. 
Creative development 
 This is where the rubber meets the road. Our 
creative consistently delivers against strategy. 
 We strive to design creative concepts that solve a 
communication problem and evoke understanding 
and feeling.
CASE STUDY: Ethyol (amifostine)—overcoming barriers to 
prevent xerostomia 
Marketing challenge 
• Ethyol was perceived as poorly tolerated with side effects, 
such as vomiting, that could interfere with radiation therapy 
• Many Radiation Oncologists believed that the need for 
cytoprotection was eliminated by advancements in radiation 
technology, such as IMRT 
Strategy 
• Make the use of Ethyol a moral obligation 
• One-two punch: 
• Consequences of xerostomia 
• Message that only Ethyol can protect patients “before it’s 
too late” 
Results 
• Ethyol was implemented into many radiation oncology 
protocols
CASE STUDY: AXIOM—Alliance for Excellence 
in Outcomes in Hematologic Malignancies 
Marketing challenge 
• Velcade was the only brand offering a true overall survival benefit 
• Many treating Hematologists had the perception that all 
chemotherapeutic options were similar 
• Product labeling limited the ability to actively promote the difference 
between Velcade and other products 
Strategy 
• Clarify that various therapies used to treat multiple myeloma 
may affect: 
– Bone disease, renal function, neuropathy, thromboembolism 
Results 
• AXIOM educational program increased the understanding of the 
effects various therapies have on serious life-threatening 
comorbidities of patients with multiple myeloma 
• Helped grow share in a increasingly crowded market and continues 
to help Velcade hold a leadership position in the multiple myeloma 
market
CASE STUDY: Teva YouTube Channel 
Marketing challenge 
• Raise awareness of the target protein clusterin 
• Communicate three core story elements: resistance, 
evasion of apoptosis, and what research reveals 
about clusterin 
Strategy 
• For SEO, create a branded YouTube channel called 
Mechanisms of Resistance in Tumors (MERIT) 
Results 
• This channel boosted search results for the exploremerit.com website and increased visibility online 
• We successfully achieved a first position in Google video search when entering the key word “clusterin” 
• The YouTube videos were viewed over 300 times in the channel’s first 3 weeks of existence
Creating lasting impressions 
Creating Awareness 
Changing Perceptions 
Raising Expectations
Matching the message to the medium
And building memorable experiences to drive value 
Driving Traffic 
Telling Stories 
Building Relationships 
Creating Buzz
Inspired to develop market-moving promotion 
Navicor won many creative 
awards in 2014: 
• Best Launch Campaign 
• Best Marketing Campaign 
• Best Healthcare Website 
• Best Corporate Video 
• Best How-To Video 
• Best Product Display 
• Best Logo 
• Best Illustration 
In 2013 we received 43 industry 
recognitions
Thank you

Weitere ähnliche Inhalte

Was ist angesagt?

Vertex Reduces EDC Study Build Times by 50%
Vertex Reduces EDC Study Build Times by 50%Vertex Reduces EDC Study Build Times by 50%
Vertex Reduces EDC Study Build Times by 50%Veeva Systems
 
Risk Based Monitoring in Clinical Trials - Impact on Sites
Risk Based Monitoring in Clinical Trials - Impact on SitesRisk Based Monitoring in Clinical Trials - Impact on Sites
Risk Based Monitoring in Clinical Trials - Impact on SitesWool Consuting Group Inc.
 
Reimagine patient safety 2030 governance through a unified safety platform
Reimagine patient safety 2030 governance through a unified safety platformReimagine patient safety 2030 governance through a unified safety platform
Reimagine patient safety 2030 governance through a unified safety platformVeeva Systems
 
Improving Clinical Trial Performance: Part 1 - Findings from the Veeva 2018 U...
Improving Clinical Trial Performance: Part 1 - Findings from the Veeva 2018 U...Improving Clinical Trial Performance: Part 1 - Findings from the Veeva 2018 U...
Improving Clinical Trial Performance: Part 1 - Findings from the Veeva 2018 U...Veeva Systems
 
Incorporating tech into your business strategy.pptx (1)
Incorporating tech into your business strategy.pptx (1)Incorporating tech into your business strategy.pptx (1)
Incorporating tech into your business strategy.pptx (1)Emily Kunka, MS, CCRP
 
Speed Clinical Trials from Start to Close: The Path to a Modern CTMS
Speed Clinical Trials from Start to Close: The Path to a Modern CTMSSpeed Clinical Trials from Start to Close: The Path to a Modern CTMS
Speed Clinical Trials from Start to Close: The Path to a Modern CTMSVeeva Systems
 
Streamlining Study Start-up
Streamlining Study Start-upStreamlining Study Start-up
Streamlining Study Start-upVeeva Systems
 
3 Reasons Intelligent Monitoring Outperforms Risk-Based Monitoring
3 Reasons Intelligent Monitoring Outperforms Risk-Based Monitoring3 Reasons Intelligent Monitoring Outperforms Risk-Based Monitoring
3 Reasons Intelligent Monitoring Outperforms Risk-Based MonitoringBioclinica
 
A Collection of DMN-Based CDSS for Sharable Clinical Guidelines - Bootstrappi...
A Collection of DMN-Based CDSS for Sharable Clinical Guidelines - Bootstrappi...A Collection of DMN-Based CDSS for Sharable Clinical Guidelines - Bootstrappi...
A Collection of DMN-Based CDSS for Sharable Clinical Guidelines - Bootstrappi...Denis Gagné
 
Clinical Trial Management System Implementation Guide
Clinical Trial Management System Implementation GuideClinical Trial Management System Implementation Guide
Clinical Trial Management System Implementation GuidePerficient, Inc.
 
CRO and Vendor Oversight: Clinical
CRO and Vendor Oversight: ClinicalCRO and Vendor Oversight: Clinical
CRO and Vendor Oversight: ClinicalManjusha Chowdhury
 
The State of Clinical Outsourcing
The State of Clinical OutsourcingThe State of Clinical Outsourcing
The State of Clinical OutsourcingThe Avoca Group
 
Best practices for implementing and maintaining successful standards
Best practices for implementing and maintaining successful standardsBest practices for implementing and maintaining successful standards
Best practices for implementing and maintaining successful standardsVeeva Systems
 
Avoca Investigative Site Survey Programs
Avoca Investigative Site Survey ProgramsAvoca Investigative Site Survey Programs
Avoca Investigative Site Survey ProgramsThe Avoca Group
 
The ABCs of Clinical Trial Management Systems
The ABCs of Clinical Trial Management SystemsThe ABCs of Clinical Trial Management Systems
The ABCs of Clinical Trial Management SystemsPerficient, Inc.
 
Managing Risks in Outsourced Clinical Trials 2014
Managing Risks in Outsourced Clinical Trials 2014Managing Risks in Outsourced Clinical Trials 2014
Managing Risks in Outsourced Clinical Trials 2014Wool Consuting Group Inc.
 
Ashfield PV Services_Trifold v6
Ashfield PV Services_Trifold v6Ashfield PV Services_Trifold v6
Ashfield PV Services_Trifold v6Holly Devine
 
The State of Unifying Clinical Systems, Processes, and Stakeholder Collaboration
The State of Unifying Clinical Systems, Processes, and Stakeholder CollaborationThe State of Unifying Clinical Systems, Processes, and Stakeholder Collaboration
The State of Unifying Clinical Systems, Processes, and Stakeholder CollaborationVeeva Systems
 

Was ist angesagt? (20)

Vertex Reduces EDC Study Build Times by 50%
Vertex Reduces EDC Study Build Times by 50%Vertex Reduces EDC Study Build Times by 50%
Vertex Reduces EDC Study Build Times by 50%
 
Risk Based Monitoring in Clinical Trials - Impact on Sites
Risk Based Monitoring in Clinical Trials - Impact on SitesRisk Based Monitoring in Clinical Trials - Impact on Sites
Risk Based Monitoring in Clinical Trials - Impact on Sites
 
Petition of the Day
Petition of the DayPetition of the Day
Petition of the Day
 
Closing Messages
Closing MessagesClosing Messages
Closing Messages
 
Reimagine patient safety 2030 governance through a unified safety platform
Reimagine patient safety 2030 governance through a unified safety platformReimagine patient safety 2030 governance through a unified safety platform
Reimagine patient safety 2030 governance through a unified safety platform
 
Improving Clinical Trial Performance: Part 1 - Findings from the Veeva 2018 U...
Improving Clinical Trial Performance: Part 1 - Findings from the Veeva 2018 U...Improving Clinical Trial Performance: Part 1 - Findings from the Veeva 2018 U...
Improving Clinical Trial Performance: Part 1 - Findings from the Veeva 2018 U...
 
Incorporating tech into your business strategy.pptx (1)
Incorporating tech into your business strategy.pptx (1)Incorporating tech into your business strategy.pptx (1)
Incorporating tech into your business strategy.pptx (1)
 
Speed Clinical Trials from Start to Close: The Path to a Modern CTMS
Speed Clinical Trials from Start to Close: The Path to a Modern CTMSSpeed Clinical Trials from Start to Close: The Path to a Modern CTMS
Speed Clinical Trials from Start to Close: The Path to a Modern CTMS
 
Streamlining Study Start-up
Streamlining Study Start-upStreamlining Study Start-up
Streamlining Study Start-up
 
3 Reasons Intelligent Monitoring Outperforms Risk-Based Monitoring
3 Reasons Intelligent Monitoring Outperforms Risk-Based Monitoring3 Reasons Intelligent Monitoring Outperforms Risk-Based Monitoring
3 Reasons Intelligent Monitoring Outperforms Risk-Based Monitoring
 
A Collection of DMN-Based CDSS for Sharable Clinical Guidelines - Bootstrappi...
A Collection of DMN-Based CDSS for Sharable Clinical Guidelines - Bootstrappi...A Collection of DMN-Based CDSS for Sharable Clinical Guidelines - Bootstrappi...
A Collection of DMN-Based CDSS for Sharable Clinical Guidelines - Bootstrappi...
 
Clinical Trial Management System Implementation Guide
Clinical Trial Management System Implementation GuideClinical Trial Management System Implementation Guide
Clinical Trial Management System Implementation Guide
 
CRO and Vendor Oversight: Clinical
CRO and Vendor Oversight: ClinicalCRO and Vendor Oversight: Clinical
CRO and Vendor Oversight: Clinical
 
The State of Clinical Outsourcing
The State of Clinical OutsourcingThe State of Clinical Outsourcing
The State of Clinical Outsourcing
 
Best practices for implementing and maintaining successful standards
Best practices for implementing and maintaining successful standardsBest practices for implementing and maintaining successful standards
Best practices for implementing and maintaining successful standards
 
Avoca Investigative Site Survey Programs
Avoca Investigative Site Survey ProgramsAvoca Investigative Site Survey Programs
Avoca Investigative Site Survey Programs
 
The ABCs of Clinical Trial Management Systems
The ABCs of Clinical Trial Management SystemsThe ABCs of Clinical Trial Management Systems
The ABCs of Clinical Trial Management Systems
 
Managing Risks in Outsourced Clinical Trials 2014
Managing Risks in Outsourced Clinical Trials 2014Managing Risks in Outsourced Clinical Trials 2014
Managing Risks in Outsourced Clinical Trials 2014
 
Ashfield PV Services_Trifold v6
Ashfield PV Services_Trifold v6Ashfield PV Services_Trifold v6
Ashfield PV Services_Trifold v6
 
The State of Unifying Clinical Systems, Processes, and Stakeholder Collaboration
The State of Unifying Clinical Systems, Processes, and Stakeholder CollaborationThe State of Unifying Clinical Systems, Processes, and Stakeholder Collaboration
The State of Unifying Clinical Systems, Processes, and Stakeholder Collaboration
 

Andere mochten auch

Patient confidentiality awareness training
Patient confidentiality awareness trainingPatient confidentiality awareness training
Patient confidentiality awareness trainingCathy Wendt
 
Patient confidentiality awareness training
Patient confidentiality awareness trainingPatient confidentiality awareness training
Patient confidentiality awareness trainingRichard Chaney
 
Say no to cervical cancer-PUBLIC Awareness-Life Care Centre_Dr.Sharda Jain
Say no to cervical cancer-PUBLIC Awareness-Life Care Centre_Dr.Sharda JainSay no to cervical cancer-PUBLIC Awareness-Life Care Centre_Dr.Sharda Jain
Say no to cervical cancer-PUBLIC Awareness-Life Care Centre_Dr.Sharda JainLifecare Centre
 
BPWI Cervical cancer awareness campaign
BPWI Cervical cancer awareness campaignBPWI Cervical cancer awareness campaign
BPWI Cervical cancer awareness campaignBPWI
 
Public Awareness Campaign Project and Presentation WebQuest
Public Awareness Campaign Project and Presentation WebQuestPublic Awareness Campaign Project and Presentation WebQuest
Public Awareness Campaign Project and Presentation WebQuestguestfc5f96
 
Presentation for public awareness
Presentation for public awarenessPresentation for public awareness
Presentation for public awarenessdrmcbansal
 
Voluntary health agencies in india
Voluntary health agencies in indiaVoluntary health agencies in india
Voluntary health agencies in indiakarthika thangaraj
 
Cervical Cancer Awareness
Cervical Cancer AwarenessCervical Cancer Awareness
Cervical Cancer Awarenessdharshinee-shri
 
Trinity Kings Family Leadership: *First Born Sons(Jesus "The King), 3-Sons, &...
Trinity Kings Family Leadership: *First Born Sons(Jesus "The King), 3-Sons, &...Trinity Kings Family Leadership: *First Born Sons(Jesus "The King), 3-Sons, &...
Trinity Kings Family Leadership: *First Born Sons(Jesus "The King), 3-Sons, &...Terrell Patillo
 
Semantic Interoperability Methodologies
Semantic Interoperability MethodologiesSemantic Interoperability Methodologies
Semantic Interoperability MethodologiesJohann Höchtl
 
W1 A4 Slideshow Conner
W1 A4 Slideshow ConnerW1 A4 Slideshow Conner
W1 A4 Slideshow ConnerTeresaLC77
 
Teepees.(Spanish/English)
Teepees.(Spanish/English)Teepees.(Spanish/English)
Teepees.(Spanish/English)Cachi Chien
 
Au Psy492 M1 A2 Ps Lewis K
Au Psy492 M1 A2 Ps Lewis KAu Psy492 M1 A2 Ps Lewis K
Au Psy492 M1 A2 Ps Lewis Klkatherine50
 
Timket Celebration in Ethiopia
Timket Celebration in EthiopiaTimket Celebration in Ethiopia
Timket Celebration in EthiopiaCachi Chien
 
Environement by MUHAMMAD FAHAD ANSARI 12IEEM 14
Environement by MUHAMMAD FAHAD ANSARI 12IEEM 14Environement by MUHAMMAD FAHAD ANSARI 12IEEM 14
Environement by MUHAMMAD FAHAD ANSARI 12IEEM 14fahadansari131
 

Andere mochten auch (17)

Ijmas 539
Ijmas 539Ijmas 539
Ijmas 539
 
Patient confidentiality awareness training
Patient confidentiality awareness trainingPatient confidentiality awareness training
Patient confidentiality awareness training
 
Patient confidentiality awareness training
Patient confidentiality awareness trainingPatient confidentiality awareness training
Patient confidentiality awareness training
 
Say no to cervical cancer-PUBLIC Awareness-Life Care Centre_Dr.Sharda Jain
Say no to cervical cancer-PUBLIC Awareness-Life Care Centre_Dr.Sharda JainSay no to cervical cancer-PUBLIC Awareness-Life Care Centre_Dr.Sharda Jain
Say no to cervical cancer-PUBLIC Awareness-Life Care Centre_Dr.Sharda Jain
 
BPWI Cervical cancer awareness campaign
BPWI Cervical cancer awareness campaignBPWI Cervical cancer awareness campaign
BPWI Cervical cancer awareness campaign
 
Public Awareness Campaign Project and Presentation WebQuest
Public Awareness Campaign Project and Presentation WebQuestPublic Awareness Campaign Project and Presentation WebQuest
Public Awareness Campaign Project and Presentation WebQuest
 
Presentation for public awareness
Presentation for public awarenessPresentation for public awareness
Presentation for public awareness
 
Voluntary health agencies in india
Voluntary health agencies in indiaVoluntary health agencies in india
Voluntary health agencies in india
 
Cervical Cancer Awareness
Cervical Cancer AwarenessCervical Cancer Awareness
Cervical Cancer Awareness
 
Trinity Kings Family Leadership: *First Born Sons(Jesus "The King), 3-Sons, &...
Trinity Kings Family Leadership: *First Born Sons(Jesus "The King), 3-Sons, &...Trinity Kings Family Leadership: *First Born Sons(Jesus "The King), 3-Sons, &...
Trinity Kings Family Leadership: *First Born Sons(Jesus "The King), 3-Sons, &...
 
Objetivos proyecto
Objetivos proyectoObjetivos proyecto
Objetivos proyecto
 
Semantic Interoperability Methodologies
Semantic Interoperability MethodologiesSemantic Interoperability Methodologies
Semantic Interoperability Methodologies
 
W1 A4 Slideshow Conner
W1 A4 Slideshow ConnerW1 A4 Slideshow Conner
W1 A4 Slideshow Conner
 
Teepees.(Spanish/English)
Teepees.(Spanish/English)Teepees.(Spanish/English)
Teepees.(Spanish/English)
 
Au Psy492 M1 A2 Ps Lewis K
Au Psy492 M1 A2 Ps Lewis KAu Psy492 M1 A2 Ps Lewis K
Au Psy492 M1 A2 Ps Lewis K
 
Timket Celebration in Ethiopia
Timket Celebration in EthiopiaTimket Celebration in Ethiopia
Timket Celebration in Ethiopia
 
Environement by MUHAMMAD FAHAD ANSARI 12IEEM 14
Environement by MUHAMMAD FAHAD ANSARI 12IEEM 14Environement by MUHAMMAD FAHAD ANSARI 12IEEM 14
Environement by MUHAMMAD FAHAD ANSARI 12IEEM 14
 

Ähnlich wie Navicor Capabilities

PAREXEL BioPharm Unit
PAREXEL BioPharm UnitPAREXEL BioPharm Unit
PAREXEL BioPharm UnitNeil Butera
 
Aagami Technology Licensing Presentation
Aagami Technology Licensing PresentationAagami Technology Licensing Presentation
Aagami Technology Licensing PresentationAagami, Inc.
 
Career Options for Pharmacists in the Industry (Singapore)
Career Options for Pharmacists in the Industry (Singapore)Career Options for Pharmacists in the Industry (Singapore)
Career Options for Pharmacists in the Industry (Singapore)yk png
 
Group4_Week10_Final_Business_Plan_VERSION_8(1)
Group4_Week10_Final_Business_Plan_VERSION_8(1)Group4_Week10_Final_Business_Plan_VERSION_8(1)
Group4_Week10_Final_Business_Plan_VERSION_8(1)roxiefoxx
 
Experience management overview - Gelb Consulting
Experience management overview - Gelb ConsultingExperience management overview - Gelb Consulting
Experience management overview - Gelb ConsultingEndeavor Management
 
5 thingsit&technologymustdotohealthcare
5 thingsit&technologymustdotohealthcare5 thingsit&technologymustdotohealthcare
5 thingsit&technologymustdotohealthcareDr Vijay Raaghavan
 
Readying Your Science for the Real World
Readying Your Science for the Real WorldReadying Your Science for the Real World
Readying Your Science for the Real WorldNoel Alaka
 
Medtech.Capabilities.Frost & Sullivan.2009
Medtech.Capabilities.Frost & Sullivan.2009Medtech.Capabilities.Frost & Sullivan.2009
Medtech.Capabilities.Frost & Sullivan.2009Siddharth Singh
 
Thomas Schwartz Resume-11-2016
Thomas Schwartz Resume-11-2016Thomas Schwartz Resume-11-2016
Thomas Schwartz Resume-11-2016Thomas Schwartz
 
Generating and Communicating Evidence to Enhance Patient Care and Product Val...
Generating and Communicating Evidence to Enhance Patient Care and Product Val...Generating and Communicating Evidence to Enhance Patient Care and Product Val...
Generating and Communicating Evidence to Enhance Patient Care and Product Val...Covance
 
Development and Co-Commercialization for Emerging Biotech organizations
Development and Co-Commercialization for Emerging Biotech organizationsDevelopment and Co-Commercialization for Emerging Biotech organizations
Development and Co-Commercialization for Emerging Biotech organizationsIndegene
 
BioClinitech- Services And Capabilities
BioClinitech- Services And CapabilitiesBioClinitech- Services And Capabilities
BioClinitech- Services And Capabilitiesshravan1198
 
Field Services: Providing On-Site, Field-Based Assistance to Support Customer...
Field Services: Providing On-Site, Field-Based Assistance to Support Customer...Field Services: Providing On-Site, Field-Based Assistance to Support Customer...
Field Services: Providing On-Site, Field-Based Assistance to Support Customer...Covance
 
Introducing StratAdviser Ltd
Introducing StratAdviser Ltd Introducing StratAdviser Ltd
Introducing StratAdviser Ltd Jan-Cedric Hansen
 
M Schleicher Resume1
M Schleicher Resume1M Schleicher Resume1
M Schleicher Resume1SchlickeN
 
Field Services: Providing On-Site, Field-Based Assistance to Support Customer...
Field Services: Providing On-Site, Field-Based Assistance to Support Customer...Field Services: Providing On-Site, Field-Based Assistance to Support Customer...
Field Services: Providing On-Site, Field-Based Assistance to Support Customer...Covance
 
Covance Phase IV Solutions Brochure
Covance Phase IV Solutions BrochureCovance Phase IV Solutions Brochure
Covance Phase IV Solutions BrochureCovance
 

Ähnlich wie Navicor Capabilities (20)

INC Research Consulting v1
INC Research Consulting v1INC Research Consulting v1
INC Research Consulting v1
 
PAREXEL BioPharm Unit
PAREXEL BioPharm UnitPAREXEL BioPharm Unit
PAREXEL BioPharm Unit
 
Aagami Technology Licensing Presentation
Aagami Technology Licensing PresentationAagami Technology Licensing Presentation
Aagami Technology Licensing Presentation
 
Career Options for Pharmacists in the Industry (Singapore)
Career Options for Pharmacists in the Industry (Singapore)Career Options for Pharmacists in the Industry (Singapore)
Career Options for Pharmacists in the Industry (Singapore)
 
Group4_Week10_Final_Business_Plan_VERSION_8(1)
Group4_Week10_Final_Business_Plan_VERSION_8(1)Group4_Week10_Final_Business_Plan_VERSION_8(1)
Group4_Week10_Final_Business_Plan_VERSION_8(1)
 
Experience management overview - Gelb Consulting
Experience management overview - Gelb ConsultingExperience management overview - Gelb Consulting
Experience management overview - Gelb Consulting
 
5 thingsit&technologymustdotohealthcare
5 thingsit&technologymustdotohealthcare5 thingsit&technologymustdotohealthcare
5 thingsit&technologymustdotohealthcare
 
Readying Your Science for the Real World
Readying Your Science for the Real WorldReadying Your Science for the Real World
Readying Your Science for the Real World
 
Medtech.Capabilities.Frost & Sullivan.2009
Medtech.Capabilities.Frost & Sullivan.2009Medtech.Capabilities.Frost & Sullivan.2009
Medtech.Capabilities.Frost & Sullivan.2009
 
Thomas Schwartz Resume-11-2016
Thomas Schwartz Resume-11-2016Thomas Schwartz Resume-11-2016
Thomas Schwartz Resume-11-2016
 
Generating and Communicating Evidence to Enhance Patient Care and Product Val...
Generating and Communicating Evidence to Enhance Patient Care and Product Val...Generating and Communicating Evidence to Enhance Patient Care and Product Val...
Generating and Communicating Evidence to Enhance Patient Care and Product Val...
 
Development and Co-Commercialization for Emerging Biotech organizations
Development and Co-Commercialization for Emerging Biotech organizationsDevelopment and Co-Commercialization for Emerging Biotech organizations
Development and Co-Commercialization for Emerging Biotech organizations
 
EPM Scientific brochure - Europe
EPM Scientific brochure - EuropeEPM Scientific brochure - Europe
EPM Scientific brochure - Europe
 
BioClinitech- Services And Capabilities
BioClinitech- Services And CapabilitiesBioClinitech- Services And Capabilities
BioClinitech- Services And Capabilities
 
Field Services: Providing On-Site, Field-Based Assistance to Support Customer...
Field Services: Providing On-Site, Field-Based Assistance to Support Customer...Field Services: Providing On-Site, Field-Based Assistance to Support Customer...
Field Services: Providing On-Site, Field-Based Assistance to Support Customer...
 
Introducing StratAdviser Ltd
Introducing StratAdviser Ltd Introducing StratAdviser Ltd
Introducing StratAdviser Ltd
 
M Schleicher Resume1
M Schleicher Resume1M Schleicher Resume1
M Schleicher Resume1
 
Field Services: Providing On-Site, Field-Based Assistance to Support Customer...
Field Services: Providing On-Site, Field-Based Assistance to Support Customer...Field Services: Providing On-Site, Field-Based Assistance to Support Customer...
Field Services: Providing On-Site, Field-Based Assistance to Support Customer...
 
Covance Phase IV Solutions Brochure
Covance Phase IV Solutions BrochureCovance Phase IV Solutions Brochure
Covance Phase IV Solutions Brochure
 
Cv upendera
Cv   upenderaCv   upendera
Cv upendera
 

Mehr von The Navicor Group

Navicor - An Oncology Focused Advertsing Agency - MedAd News profile
Navicor - An Oncology Focused Advertsing Agency - MedAd News profileNavicor - An Oncology Focused Advertsing Agency - MedAd News profile
Navicor - An Oncology Focused Advertsing Agency - MedAd News profileThe Navicor Group
 
Navicor, The Oncology Agency
Navicor, The Oncology AgencyNavicor, The Oncology Agency
Navicor, The Oncology AgencyThe Navicor Group
 
The trojan horse of oncology therapies
The trojan horse of oncology therapiesThe trojan horse of oncology therapies
The trojan horse of oncology therapiesThe Navicor Group
 
The Navicor Group, PharmaVOICE For Art's Sake review
The Navicor Group, PharmaVOICE For Art's Sake reviewThe Navicor Group, PharmaVOICE For Art's Sake review
The Navicor Group, PharmaVOICE For Art's Sake reviewThe Navicor Group
 
The Navicor Group, MM&M Top 75 Agencies
The Navicor Group, MM&M Top 75 AgenciesThe Navicor Group, MM&M Top 75 Agencies
The Navicor Group, MM&M Top 75 AgenciesThe Navicor Group
 
The Navicor Group, MM&M Top 60 Agencies
The Navicor Group, MM&M Top 60 AgenciesThe Navicor Group, MM&M Top 60 Agencies
The Navicor Group, MM&M Top 60 AgenciesThe Navicor Group
 
Media biovaxid pharmavoicejune2007-1
Media biovaxid pharmavoicejune2007-1Media biovaxid pharmavoicejune2007-1
Media biovaxid pharmavoicejune2007-1The Navicor Group
 

Mehr von The Navicor Group (9)

FDA Draft Social Guidance
FDA Draft Social GuidanceFDA Draft Social Guidance
FDA Draft Social Guidance
 
Navicor - An Oncology Focused Advertsing Agency - MedAd News profile
Navicor - An Oncology Focused Advertsing Agency - MedAd News profileNavicor - An Oncology Focused Advertsing Agency - MedAd News profile
Navicor - An Oncology Focused Advertsing Agency - MedAd News profile
 
Navicor, The Oncology Agency
Navicor, The Oncology AgencyNavicor, The Oncology Agency
Navicor, The Oncology Agency
 
YouTube for Oncologists
YouTube for Oncologists YouTube for Oncologists
YouTube for Oncologists
 
The trojan horse of oncology therapies
The trojan horse of oncology therapiesThe trojan horse of oncology therapies
The trojan horse of oncology therapies
 
The Navicor Group, PharmaVOICE For Art's Sake review
The Navicor Group, PharmaVOICE For Art's Sake reviewThe Navicor Group, PharmaVOICE For Art's Sake review
The Navicor Group, PharmaVOICE For Art's Sake review
 
The Navicor Group, MM&M Top 75 Agencies
The Navicor Group, MM&M Top 75 AgenciesThe Navicor Group, MM&M Top 75 Agencies
The Navicor Group, MM&M Top 75 Agencies
 
The Navicor Group, MM&M Top 60 Agencies
The Navicor Group, MM&M Top 60 AgenciesThe Navicor Group, MM&M Top 60 Agencies
The Navicor Group, MM&M Top 60 Agencies
 
Media biovaxid pharmavoicejune2007-1
Media biovaxid pharmavoicejune2007-1Media biovaxid pharmavoicejune2007-1
Media biovaxid pharmavoicejune2007-1
 

Navicor Capabilities

  • 1. ONCOLOGY September, 2014 This information is confidential and copyrighted by The Navicor Group Inc., Westerville, OH.
  • 2. We are driven by a passion for transforming products into brands and patients into survivors.
  • 3. The Navicor Group • is a 100% healthcare-focused, full-service agency • understands the unique aspects of the oncology marketplace • has extensive launch experience • has broad and vast oncology experience • has partnerships with large and small pharma and biotech companies • is part of the inVentiv Health family of companies
  • 4. Accelerating performance inVentiv Health offers best-in-class clinical, consulting, and commercial services to global companies seeking to accelerate performance. With 13,600 employees in 40 countries, we rapidly transform promising ideas into commercial reality. 4
  • 5. Core capabilities Services include:  Outsourced sales teams and sales support  Advertising, branding and PR  Digital and closed loop marketing  Patient outcomes, REMS and Rx access/adherence  Medical education Services include:  Phase I-II (FIH or bioequivalence studies)  Phase IIb – Phase IV studies  Strategic partnerships  Bioanalytical services  Clinical data services/technology  Staffing services Consulting practices include:  Brand management  Business development  Clinical development  Medical affairs  Pricing and market access  Sales One of the industry’s top global CROs World’s leading provider of sales, marketing, and communications solutions for the healthcare industry The leading management consulting group specializing in biopharma 5
  • 6. Access to convergent services to solve challenges Public relations Patient access Sales force deployment KOL development Patient education Market research Launch planning CRM Publication planning Clinical
  • 7. Transcending every intersection point along the life cycle continuum 7 Scientific Platform Disease Awareness Advisory Boards Service Brands Direct to Patient Core Promotional Execution Consultancy Core Messaging Specialized Services Digital Strategy and Relationship Marketing Tactical and Channel Planning Brand Strategy Customer Insights Branding and Campaign Oncology/Hematology Centers of Excellence
  • 8. Our collective experience is broad and deep Custirsen Ganetespib Apatorsen Bold denotes current clients Vosaroxin Rociletinib Rolapitant
  • 9. Navicor has unmatched experience in working with companies to transform development into their first commercial reality Our experience can benefit you in a multitude of ways Market prep and launch (products not yet available)  Thorough knowledge of oncology  Position the product and the company  Understand OPDP reviews  Traditional and accelerated filings  Work within limited commercial infrastructure Market prep and launch AOR assignments  Define and shape new expectations for a disease  Partner across the commercial players: − Market planning − Sales training − Medical affairs  Efficiency across commercial needs
  • 10. Our account management philosophy is rooted in partnership Clearly define expectations Successful partnership and brand success Timely feedback Honest transparency Continuous dialogue Subjective and objective metrics
  • 11. Agency Philosophy We believe we can make a difference Each one of us is inspired by the patients whose lives we help touch. We are motivated to set expectations, think originally, and behave differently. We believe that everyone is an idea person We operate in an intimate structure free from traditional agency barriers. Creative and strategy are not limited to certain departments. We believe intellectual rigor is imperative Creative communication and strategy must go beyond current indications and demonstrate foresight with regard to emerging data. We believe in collaborative relationships Our ideal client-agency partnership is one that fosters connections. We want to foster relationships with clients who are looking to improve patient outcomes
  • 12. Based on years of client feedback, our areas of strength include: Scientific acumen • We hold ourselves accountable to be specialists in the field of oncology. • We have seasoned executives with broad oncology experience and PhD-level writers who specialize in oncology. Strategic thinking  By focusing on oncology, we are able to go into greater depth of strategic thought about our clients’ products and challenges.  We truly understand market implications within the oncology space and develop appropriate plans and programs to address key insights. Collaborative relationships  We believe that our best work is done in collaboration within our agency structure and with our clients.  We get the best results and have more fun when we collaborate. Creative development  This is where the rubber meets the road. Our creative consistently delivers against strategy.  We strive to design creative concepts that solve a communication problem and evoke understanding and feeling.
  • 13. CASE STUDY: Ethyol (amifostine)—overcoming barriers to prevent xerostomia Marketing challenge • Ethyol was perceived as poorly tolerated with side effects, such as vomiting, that could interfere with radiation therapy • Many Radiation Oncologists believed that the need for cytoprotection was eliminated by advancements in radiation technology, such as IMRT Strategy • Make the use of Ethyol a moral obligation • One-two punch: • Consequences of xerostomia • Message that only Ethyol can protect patients “before it’s too late” Results • Ethyol was implemented into many radiation oncology protocols
  • 14. CASE STUDY: AXIOM—Alliance for Excellence in Outcomes in Hematologic Malignancies Marketing challenge • Velcade was the only brand offering a true overall survival benefit • Many treating Hematologists had the perception that all chemotherapeutic options were similar • Product labeling limited the ability to actively promote the difference between Velcade and other products Strategy • Clarify that various therapies used to treat multiple myeloma may affect: – Bone disease, renal function, neuropathy, thromboembolism Results • AXIOM educational program increased the understanding of the effects various therapies have on serious life-threatening comorbidities of patients with multiple myeloma • Helped grow share in a increasingly crowded market and continues to help Velcade hold a leadership position in the multiple myeloma market
  • 15. CASE STUDY: Teva YouTube Channel Marketing challenge • Raise awareness of the target protein clusterin • Communicate three core story elements: resistance, evasion of apoptosis, and what research reveals about clusterin Strategy • For SEO, create a branded YouTube channel called Mechanisms of Resistance in Tumors (MERIT) Results • This channel boosted search results for the exploremerit.com website and increased visibility online • We successfully achieved a first position in Google video search when entering the key word “clusterin” • The YouTube videos were viewed over 300 times in the channel’s first 3 weeks of existence
  • 16. Creating lasting impressions Creating Awareness Changing Perceptions Raising Expectations
  • 17. Matching the message to the medium
  • 18. And building memorable experiences to drive value Driving Traffic Telling Stories Building Relationships Creating Buzz
  • 19. Inspired to develop market-moving promotion Navicor won many creative awards in 2014: • Best Launch Campaign • Best Marketing Campaign • Best Healthcare Website • Best Corporate Video • Best How-To Video • Best Product Display • Best Logo • Best Illustration In 2013 we received 43 industry recognitions

Hinweis der Redaktion

  1. MB
  2. MB
  3. LK
  4. LK
  5. LK
  6. MB
  7. LK
  8. TTA
  9. MB
  10. MB
  11. MB
  12. MB
  13. MB